Quest Laboratories lists at 60% premium on NSE SME

Shares of Quest Laboratories Limited made impressive debut on NSE SME platform on May 23, listing at ₹ 155, premium of 60 percent over issue price of ₹ 97.

[{"selector":"#anim-4bf033da-8993-46fe-8381-0245d457e2a6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1a737d31-1f6a-453b-8f3a-2c6dad27f8ad","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Quest Laboratories IPO

The ₹ 43.16-crore public offer of Quest Laboratories garnered robust investor interest, being subscribed over 85 times. Non-institutional investors led charge, purchasing 184 times their allotted quota.

[{"selector":"#anim-f98b2b16-0421-45e1-944d-1a5e63007c3a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-59108015-b071-420a-8b8f-820866784d35","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

Retail investors showed significant interest, buying 58 times portion set aside for them. Qualified Institutional Buyers (QIBs) were also active, purchasing 57 times their allotted portion.

[{"selector":"#anim-811f54ee-dfe7-4928-b198-5168fd70ccfd","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-03f60b24-95fd-47f6-806a-b78dd121f7fd","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

Established in 1998, Quest Laboratories Limited is pharmaceutical company manufacturing range of medications including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, & antidepressants.

[{"selector":"#anim-1197f918-b23d-46c8-800b-4788ae004425","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1532ac24-b35d-4b5b-9646-db4c668ecb2e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-0775d31c-dc06-4cb2-a712-268f03cd20a6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fc49f3ee-f5d1-48f3-96eb-b1a02943784c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-dc0d8c5b-3fef-47e1-bf9f-3ec37c9a240e","keyframes":{"transform":["translate3d(-120.06472%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Swipe up to Open Demat Account Open Demat Account

Check out more 5paisa webstories

[{"selector":"#anim-31f3ab31-dfc6-4f9e-9675-452b391ee584","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1a685b83-a136-4014-843f-663c302989a3","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6d413857-e45e-4bc8-8944-efefa4968f4a","keyframes":{"transform":["translate3d(0px, 561.27896%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Quest Laboratories lists at 60% premium on NSE SME

Shares of Quest Laboratories Limited made impressive debut on NSE SME platform on May 23, listing at ₹ 155, premium of 60 percent over issue price of ₹ 97.

Quest Laboratories' Impressive Debut

The ₹ 43.16-crore public offer of Quest Laboratories garnered robust investor interest, being subscribed over 85 times. Non-institutional investors led charge, purchasing 184 times their allotted quota.

Robust Investor Interest

Retail investors showed significant interest, buying 58 times portion set aside for them. Qualified Institutional Buyers (QIBs) were also active, purchasing 57 times their allotted portion.

Retail & QIB Participation

Established in 1998, Quest Laboratories Limited is pharmaceutical company manufacturing range of medications including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, & antidepressants.

About Quest Laboratories

Check out more 5paisa webstories

Swipe up